Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.27
(-44.94%)
USD 0.27
(-44.94%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 14.67 Million USD | -5.74% |
| 2022 | 15.56 Million USD | -38.47% |
| 2021 | 25.3 Million USD | 7.83% |
| 2020 | 23.46 Million USD | 21.04% |
| 2019 | 19.38 Million USD | 1.1% |
| 2018 | 19.17 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 2.94 Million USD | 0.0% |
| 2024 Q1 | 2.94 Million USD | 5.62% |
| 2023 Q4 | 2.78 Million USD | 0.0% |
| 2023 Q1 | 4.54 Million USD | 113.21% |
| 2023 FY | 14.67 Million USD | -5.74% |
| 2023 Q3 | 2.78 Million USD | -69.34% |
| 2023 Q2 | 9.09 Million USD | 100.0% |
| 2022 Q2 | 8.66 Million USD | 55.66% |
| 2022 FY | 15.56 Million USD | -38.47% |
| 2022 Q1 | 5.56 Million USD | -24.65% |
| 2022 Q4 | 2.13 Million USD | -3.46% |
| 2022 Q3 | 2.2 Million USD | -74.51% |
| 2021 Q4 | 7.39 Million USD | 0.0% |
| 2021 Q3 | 7.39 Million USD | 28.77% |
| 2021 Q2 | 5.73 Million USD | 0.0% |
| 2021 Q1 | 5.73 Million USD | 7.74% |
| 2021 FY | 25.3 Million USD | 7.83% |
| 2020 Q2 | 6.4 Million USD | -0.0% |
| 2020 FY | 23.46 Million USD | 21.04% |
| 2020 Q4 | 5.32 Million USD | 0.0% |
| 2020 Q3 | 5.32 Million USD | -16.84% |
| 2020 Q1 | 6.4 Million USD | 92.21% |
| 2019 Q1 | 6.36 Million USD | 0.0% |
| 2019 Q4 | 3.33 Million USD | 0.0% |
| 2019 Q3 | 3.33 Million USD | -47.6% |
| 2019 Q2 | 6.36 Million USD | 0.0% |
| 2019 FY | 19.38 Million USD | 1.1% |
| 2018 FY | 19.17 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 125.447% |
| AngioDynamics, Inc. | -97.71 Million USD | 115.018% |
| AtriCure, Inc. | -26.68 Million USD | 154.997% |
| Avinger, Inc. | -16.63 Million USD | 188.217% |
| Azenta, Inc. | -73.12 Million USD | 120.068% |
| BioLife Solutions, Inc. | -70.82 Million USD | 120.72% |
| The Cooper Companies, Inc. | 533.1 Million USD | 97.247% |
| Daxor Corporation | -177.07 Thousand USD | 8387.414% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 197.108% |
| Femasys Inc. | -14.5 Million USD | 201.148% |
| GlucoTrack, Inc. | -7.1 Million USD | 306.573% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -674.812% |
| Hologic, Inc. | 882.6 Million USD | 98.337% |
| ICU Medical, Inc. | 22.82 Million USD | 35.707% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 99.169% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 242.892% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 60.426% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 312.664% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 312.664% |
| Masimo Corporation | 136.5 Million USD | 89.249% |
| Microbot Medical Inc. | -9.85 Million USD | 248.909% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 88.16% |
| Nephros, Inc. | -1.59 Million USD | 1021.214% |
| NovoCure Limited | -232.87 Million USD | 106.302% |
| NEXGEL, Inc. | -3.47 Million USD | 522.057% |
| NEXGEL, Inc. | -3.47 Million USD | 522.057% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 114.275% |
| OraSure Technologies, Inc. | 54.07 Million USD | 72.864% |
| Pro-Dex, Inc. | 7.17 Million USD | -104.586% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 133.678% |
| Predictive Oncology Inc. | -13.92 Million USD | 205.413% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 638.662% |
| QuidelOrtho Corporation | 139.1 Million USD | 89.45% |
| Repligen Corporation | 54.57 Million USD | 73.111% |
| Sanara MedTech Inc. | -4.21 Million USD | 448.147% |
| STAAR Surgical Company | 28.09 Million USD | 47.77% |
| Sharps Technology, Inc. | -10.12 Million USD | 244.914% |
| Utah Medical Products, Inc. | 16.77 Million USD | 12.529% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 117.265% |
| Jin Medical International Ltd. | 2.86 Million USD | -411.81% |